NTNG1
Basic information
Region (hg38): 1:107140007-107484923
Links
Phenotypes
GenCC
Source:
- atypical Rett syndrome (Supportive), mode of inheritance: AD
- syndromic intellectual disability (Supportive), mode of inheritance: AD
- complex neurodevelopmental disorder (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NTNG1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 26 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 10 | 11 | ||||
Total | 0 | 0 | 27 | 2 | 16 |
Variants in NTNG1
This is a list of pathogenic ClinVar variants found in the NTNG1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-107148301-A-G | Benign (Jun 20, 2021) | |||
1-107148474-G-C | Benign (Jun 20, 2021) | |||
1-107148668-G-A | Benign (Jun 05, 2018) | |||
1-107148795-C-A | not specified | Uncertain significance (Jul 30, 2024) | ||
1-107149019-T-C | Benign (Jun 20, 2021) | |||
1-107324330-C-G | not specified | Uncertain significance (May 30, 2023) | ||
1-107324416-C-G | NTNG1-related disorder | Benign (Mar 30, 2018) | ||
1-107324435-A-G | not specified | Uncertain significance (Jul 14, 2021) | ||
1-107324443-G-A | NTNG1-related disorder | Benign (Jun 13, 2018) | ||
1-107324465-C-T | NTNG1-related disorder | Benign (Sep 01, 2023) | ||
1-107324617-G-C | not specified | Uncertain significance (Dec 07, 2021) | ||
1-107324620-T-G | not specified | Uncertain significance (Sep 30, 2021) | ||
1-107324669-A-C | not specified | Uncertain significance (Oct 02, 2023) | ||
1-107324724-C-T | Uncertain significance (-) | |||
1-107324830-G-T | not specified | Uncertain significance (Jan 03, 2024) | ||
1-107324874-A-G | not specified | Uncertain significance (Sep 20, 2023) | ||
1-107324876-T-C | Likely benign (Sep 01, 2023) | |||
1-107324881-A-G | Benign (Jun 10, 2021) | |||
1-107324896-G-A | NTNG1-related disorder | Likely benign (Dec 23, 2019) | ||
1-107325019-C-T | Benign (Jun 19, 2021) | |||
1-107325095-A-C | Benign (Jun 19, 2021) | |||
1-107394846-C-G | Benign (Jun 20, 2021) | |||
1-107395159-A-C | not specified | Uncertain significance (May 16, 2024) | ||
1-107395206-A-G | not specified | Uncertain significance (Apr 25, 2023) | ||
1-107407690-A-G | not specified | Uncertain significance (Oct 09, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NTNG1 | protein_coding | protein_coding | ENST00000370068 | 7 | 343452 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.917 | 0.0833 | 125650 | 0 | 26 | 125676 | 0.000103 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.45 | 193 | 316 | 0.611 | 0.0000177 | 3530 |
Missense in Polyphen | 59 | 134.75 | 0.43783 | 1547 | ||
Synonymous | 0.429 | 125 | 131 | 0.952 | 0.00000861 | 1023 |
Loss of Function | 3.96 | 4 | 25.6 | 0.156 | 0.00000143 | 297 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000166 | 0.000163 |
Finnish | 0.000698 | 0.000693 |
European (Non-Finnish) | 0.0000446 | 0.0000440 |
Middle Eastern | 0.000166 | 0.000163 |
South Asian | 0.0000981 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in controlling patterning and neuronal circuit formation at the laminar, cellular, subcellular and synaptic levels. Promotes neurite outgrowth of both axons and dendrites. {ECO:0000269|PubMed:21946559}.;
- Pathway
- Cell adhesion molecules (CAMs) - Homo sapiens (human);Axon guidance - Homo sapiens (human);Splicing factor NOVA regulated synaptic proteins;Post-translational modification: synthesis of GPI-anchored proteins;Post-translational protein modification;Metabolism of proteins
(Consensus)
Recessive Scores
- pRec
- 0.104
Intolerance Scores
- loftool
- 0.268
- rvis_EVS
- -0.67
- rvis_percentile_EVS
- 15.62
Haploinsufficiency Scores
- pHI
- 0.0519
- hipred
- Y
- hipred_score
- 0.713
- ghis
- 0.578
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.589
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ntng1
- Phenotype
Gene ontology
- Biological process
- axonogenesis;modulation of chemical synaptic transmission;synaptic membrane adhesion
- Cellular component
- extracellular region;plasma membrane;anchored component of plasma membrane;Schaffer collateral - CA1 synapse;glutamatergic synapse;anchored component of presynaptic active zone membrane
- Molecular function
- protein binding;cell adhesion molecule binding;cell-cell adhesion mediator activity